| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 10/27/2004 | EP1469855A2 Methods of treating patients suffering from movement disorders |
| 10/27/2004 | EP1315728B1 Process for the preparation of vitronectin receptor antagonists |
| 10/27/2004 | CN1541278A Novel molecular target for neurotoxicity |
| 10/26/2004 | US6809091 Substances capable of inducing apoptosis |
| 10/21/2004 | WO2004089953A1 Purin-6-one-derivatives |
| 10/21/2004 | WO2004089952A1 Novel crystalline forms of abacavir sulfate |
| 10/21/2004 | WO2004039808A3 Process for the preparation of ganciclovir |
| 10/21/2004 | WO2004006867A3 2-amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purine antiviral agents |
| 10/21/2004 | US20040209899 A2B adenosine receptor antagonists |
| 10/21/2004 | US20040209889 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 10/21/2004 | CA2517336A1 Purin-6-one-derivatives |
| 10/20/2004 | EP1467990A1 Process for producing dioxolane nucleoside analogues |
| 10/20/2004 | EP0727959B1 Diagnostic uses of hydrazinoadenosines |
| 10/20/2004 | CN1171888C Substituted purin derivatives, preparation method and use |
| 10/19/2004 | US6806375 Process for the production of purine derivatives and intermediates therefor |
| 10/19/2004 | US6806270 Selective antagonists of A2B adenosine receptors |
| 10/14/2004 | WO2004088312A2 Fluorescently tagged ligands |
| 10/14/2004 | WO2004087053A2 Dipeptidyl peptidase inhibitors |
| 10/14/2004 | US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
| 10/14/2004 | US20040204429 Reversible inhibitors of SAH hydrolase and uses thereof |
| 10/14/2004 | US20040204428 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments |
| 10/14/2004 | CA2521113A1 Fluorescently tagged ligands |
| 10/14/2004 | CA2518465A1 Dipeptidyl peptidase inhibitors |
| 10/13/2004 | EP1466919A1 Nucleotide analogs with six membered rings |
| 10/13/2004 | EP1465894A2 Synthesis and purification of valacyclovir |
| 10/13/2004 | EP1202628B1 Novel hypoxanthine and thiohypoxanthine compounds |
| 10/12/2004 | US6803457 Adenosine receptors; for reduction of tissue damage resulting from hypoxia/cardiovascular disorders in mammals/humans |
| 10/12/2004 | US6803371 For treating cellular proliferative and neurodegenerative diseases |
| 10/07/2004 | WO2004085421A2 Bioreductively-activated prodrugs |
| 10/07/2004 | WO2003105770A3 Carbocyclic nucleoside analogs as rna-antivirals |
| 10/07/2004 | US20040198753 administering adenosine receptor antagonist ; side effect reduction; parkinson's disease |
| 10/07/2004 | US20040198725 A bi-heterocyclic compound e.g 3-methoxyphenyl)-{6-Morpholin-4-yl-2-[2-(pyridin-2-yloxy)-ethoxy]-9H-purin-8-yl}-amine or other derivatives useful for treating an interleukin-12 overproduction-related disorder such as rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis or diabetes |
| 10/07/2004 | US20040198718 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 10/07/2004 | US20040198693 Purine-type compounds: A3 agonists |
| 10/07/2004 | US20040198691 Partial and full agonists of A1 adenosine receptors |
| 10/07/2004 | US20040197396 medicament for the treatment or prophylaxis of a herpes viral infection; high degree of robustness, highly regulated; administering the drug to mammals |
| 10/07/2004 | CA2519901A1 Bioreductively-activated prodrugs |
| 10/06/2004 | EP1463727A2 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| 10/06/2004 | EP1463707A2 A group of novel anti-cancer compounds with specific structure |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors |
| 10/06/2004 | CN1169810C Peptide nucleic acid derivatives and preparing process, intermediate for preparing them and medicinal composition containing them |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 09/30/2004 | WO2004021979A3 PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS |
| 09/30/2004 | US20040192912 Isolation, purification using absorptive polymer; epoxidation, hydrolysis |
| 09/30/2004 | US20040192783 Use of B-2 bronchodilator drugs |
| 09/30/2004 | US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents |
| 09/30/2004 | US20040192708 Sulfonamide substituted xanthine derivatives |
| 09/30/2004 | US20040192707 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 09/30/2004 | DE10312353A1 New 8-(3-amino-piperidin-1-yl)-xanthine derivatives are dipeptidylpeptidase-IV inhibitors useful for, e.g. treating diabetes mellitus, arthritis or obesity |
| 09/29/2004 | EP1090019B1 Adenosine derivatives |
| 09/23/2004 | WO2004069185A3 Partial and full agonists of a1 adenosine receptors |
| 09/23/2004 | WO2004038006A3 Purine nucleosides |
| 09/23/2004 | US20040186129 2-Aroylimidazole compounds for treating cancer |
| 09/23/2004 | US20040185352 Photothermographic element comprising improved base precursors and methods for their use |
| 09/22/2004 | EP1460077A1 Novel pyrazolopyrimidones and their use as PDE inhibitors |
| 09/22/2004 | EP1460074A1 Substituted amino alkyl compounds |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531444A Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using same |
| 09/21/2004 | US6794390 Treating cell proliferative disorders such as rheumatoid arthritis, lupus, type i diabetes, multiple sclerosis, cancer, restenosis, host graft disease, gout, and polycystic kidney disease. |
| 09/21/2004 | US6794372 Nitrate salts of antimicrobial agents |
| 09/16/2004 | WO2004078943A2 Alternative heterocycles for dna recognition |
| 09/16/2004 | WO2003105666A3 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040180897 anticarcinogenic agents |
| 09/15/2004 | EP1456209A1 A2a adenosine receptor antagonists |
| 09/15/2004 | CN1166678C Purine derivatives |
| 09/15/2004 | CN1166666C Fused imiazole compounds and remedies for diabetes mellitus |
| 09/14/2004 | US6790958 Purine inhibitors of cyclin dependent kinase 2 & IKBA |
| 09/14/2004 | US6790841 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents |
| 09/10/2004 | WO2004048380A8 Process for the synthesis of ganciclovir |
| 09/10/2004 | WO2004047769A3 Benzimidazoles and analogs thereof as antibacterials |
| 09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 09/09/2004 | US20040176399 A2B adenosine receptor antagonists |
| 09/08/2004 | EP1453834A1 Anhydrous crystal form of valaciclovir hydrochloride |
| 09/08/2004 | EP1453833A2 A process for the preparation of ganciclovir intermediate n2-acetyl-9-(1,3-diacetoxy-2-propoxymethyl) guanine |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | CN1526712A Synthesis of 4-[[3-(1,6-dihydro-6-oxo-9H-purine-9-radical)-1-oxopropyl]amino] benzoic acid and its salt or ester |
| 09/08/2004 | CN1165536C Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 09/02/2004 | WO2004074288A1 Sulfonamide substituted xanthine derivatives for use as pepck inhibitors |
| 09/02/2004 | WO2004074287A1 Novel compounds |
| 09/02/2004 | WO2004074278A1 Novel compounds |
| 09/02/2004 | WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | WO2004074247A2 A1 adenosine receptor antagonists |
| 09/02/2004 | WO2004073595A2 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | CA2516250A1 A1 adenosine receptor antagonists |
| 09/02/2004 | CA2516235A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | CA2515610A1 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 09/02/2004 | CA2514472A1 Sulfonamide substituted xanthine derivatives for use as pepck inhibitors |
| 09/01/2004 | EP1452528A1 Xanthine oxidase inhibitors |
| 09/01/2004 | EP1450844A2 Polymeric thiol-linked prodrugs employing benzyl elimination systems |
| 09/01/2004 | CN1525974A Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 09/01/2004 | CN1525960A Lorenz Gisela |
| 08/31/2004 | US6784189 Potassium channel inhibitors and method |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/26/2004 | WO2004052288A3 2-nh-heteroarylimidazoles with antibacterial activity |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167137 Xanthine phosphodiesterase V inhibitors |
| 08/26/2004 | US20040166125 Xanthine derivatives, their preparation and their use in pharmaceutical compositions |